[Treatment of hypertension in the elderly].
Hohage
Helge
H
Medizinische Klinik und Poliklinik D, Universitätsklinikum Münster, Münster. hohage@uni-muenster.de
Gerhardt
Ulf
U
Suwelack
Barbara M
BM
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000367:Age Factors; D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000008:administration & dosage / Q000627:therapeutic use; D003327:Coronary Disease / Q000150:complications; D016757:Death, Sudden, Cardiac / Q000517:prevention & control; D048909:Diabetes Complications; D004232:Diuretics / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006333:Heart Failure / Q000517:prevention & control; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000401:mortality / Q000628:therapy*; D008297:Male; D015201:Meta-Analysis as Topic; D008875:Middle Aged; D009203:Myocardial Infarction / Q000517:prevention & control; D010353:Patient Education as Topic; D010919:Placebos; D016032:Randomized Controlled Trials as Topic; D012306:Risk; D012307:Risk Factors; D020521:Stroke / Q000517:prevention & control; D013997:Time Factors; D014944:World Health Organization
D000317:Adrenergic alpha-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D004232:Diuretics; D010919:Placebos